Niraj Mishra

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

A High-Throughput Yellow Fever Neutralization Assay.

A High-Throughput Yellow Fever Neutralization Assay.

Journal: Microbiology spectrum
Published: June 07, 2022

Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.

Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice.

Journal: Emerging microbes & infections
Published: November 18, 2021

A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses.

A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses.

Journal: Vaccines
Published: September 01, 2021

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.

Journal: Nature
Published: July 15, 2020

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.

Journal: mBio
Published: April 09, 2020

A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.

A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice.

Journal: Emerging microbes & infections
Published: March 03, 2020

Limited evolution of the yellow fever virus 17d in a mouse infection model.

Limited evolution of the yellow fever virus 17d in a mouse infection model.

Journal: Emerging microbes & infections
Published: December 05, 2019

A yellow fever-Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice.

A yellow fever-Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice.

Journal: NPJ vaccines
Published: March 19, 2018

A rat model for hepatitis E virus.

A rat model for hepatitis E virus.

Journal: Disease models & mechanisms
Published: December 15, 2015

Clot stability and fibrin deposition is strongly reduced in mice in which mouse TAFI is replaced by human TAFI.

Clot stability and fibrin deposition is strongly reduced in mice in which mouse TAFI is replaced by human TAFI.

Journal: Thrombosis research
Published: March 26, 2014
Showing 1-10 of 10

Last Updated: 09/26/2026